iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.
Ticker SymbolICAD
CompanyICAD Inc
CEOMs. Dana R. Brown
Websitehttps://www.icadmed.com/
FAQs
What is the current price of ICAD Inc (ICAD)?
The current price of ICAD Inc (ICAD) is 3.870.
What is the symbol of ICAD Inc?
The ticker symbol of ICAD Inc is ICAD.
What is the 52-week high of ICAD Inc?
The 52-week high of ICAD Inc is 4.015.
What is the 52-week low of ICAD Inc?
The 52-week low of ICAD Inc is 1.190.
What is the market capitalization of ICAD Inc?
The market capitalization of ICAD Inc is 105.19M.
What is the net income of ICAD Inc?
The net income of ICAD Inc is -5.62M.
Is ICAD Inc (ICAD) currently rated as Buy, Hold, or Sell?
According to analysts, ICAD Inc (ICAD) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of ICAD Inc (ICAD)?
The Earnings Per Share (EPS TTM) of ICAD Inc (ICAD) is -0.031.